Patients use a HIPAA-compliant mobile application to record videos of themselves taking their medication. This creates accountability and encourages communication with providers when needed. Providers benefit from dose-by-dose adherence data to better serve patient needs.
With HIPAA-secure mobile communication tools integrated into the platform, it’s easy to send patients notes of encouragement or check in when they miss their medication.
Focus your attention on patients who need it most. Use emocha’s smart filtering to quickly sort patients struggling with adherence, experiencing side effects, or even reporting cravings for opioid use disorder.
In a National Institute of Minority Health and Health Disparities Small Business Innovation Research grant across 3 Maryland public health departments, 100% of patients successfully completed tuberculosis treatment
Everyone saves when patients take their medication. Hospitals reduce readmissions, health plans save on downstream expenditures, and DOT programs cut down on daily transportation time. Most importantly, patient health improves when medication is taken properly.
In Seattle, the public health dept has used emocha for medication adherence in tuberculosis since 2016. Meanwhile, University of Washington Medicine’s Harborview Medical Center began using emocha to help patients with hepatitis C who are intravenous drug users stay adherent to their medication. Recognizing the benefit that the technology could have with these patients, Harborview decided to expand their use of emocha to include patients in treatment for opioid use disorder.
Rhode Island Department of Health, in conjunction with The Miriam Hospital, is using emocha’s video DOT for all of its patients with tuberculosis statewide. The Miriam Hospital also uses emocha as a part of a multi-city study to determine where video DOT helps patients with hepatitis C who were intravenous drug users stay adherent to their medication. Nearby Harvard-affiliated Massachusetts General Hospital is another participant in the study.
Texas is a pioneer in using video DOT to monitor dose by dose adherence for patients with tuberculosis. Harris County was the first in the country to implement emocha’s asynchronous video DOT for its patients with tuberculosis in 2014.
"Progress against Tuberculosis today is the result of intensive efforts over the past 15 years to implement Dirctly Observed Therapy" The Millennium Development Goals Report 2011
Directly Observed Therapy (DOT) has been the gold standard for medication adherence since the 1950s. Visually verifying every dose in person has been shown to achieve over 90 percent adherence rates. However, it’s also expensive and time-consuming for patients and providers. emocha makes DOT more accessible. We understand that patient-provider communication is core to DOT, and our asynchronous video DOT platform enables engagement beyond in-person visits. Backed by world-renowned clinical experts and data from the National Institutes of Health, emocha is the leading adherence platform.